InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-10.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Beetham Thomas W., Autre. Insider active across 2 companies, notably Magenta Therapeutics, Inc.. In total, 7 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €140k. Activity tracked since 14 September 2021. The latest transaction was disclosed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Beetham Thomas W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,048 股@ US$30.1942.9% 占其流量Common StockSEC:0001193125-26-099014:0
9,409 股Common StockSEC:0001193125-26-092040:0
5,000 股@ US$23.41100.0% 占其流量Common StockSEC:0000950170-24-110485:0
标准退出：2024年12月26日 (T+90)
3,000 股@ US$0.943.6% 占其流量Common StockSEC:0000899243-22-037435:0
3,000 股@ US$0.996.8% 占其流量Common StockSEC:0000899243-22-021182:0
6,103 股@ US$6.7386.4% 占其流量Common StockSEC:0000899243-21-036598:0
20,000 股0Common StockSEC:0000899243-21-036332:0
7 条申报中的 7 条
About Beetham Thomas W.
Beetham Thomas W. is a declarant linked to Magenta Therapeutics, Inc. and Viridian Therapeutics, Inc.\DE, where the role is listed as Autre and Chief Operating Officer. Across 7 filings in total, the 7 sampled filings cover the period from 2021-09-16 to 2026-03-09, with EUR 104722 of buys and EUR 34904 of sells, and the most frequent transaction nature is Attribution.
